InvestorsHub Logo
Followers 9
Posts 920
Boards Moderated 0
Alias Born 04/21/2014

Re: None

Thursday, 11/16/2017 1:22:00 PM

Thursday, November 16, 2017 1:22:00 PM

Post# of 37496
CEO_Andrey_I_am_Happy_With_You_As_an_OMHE_Shareholder


FY2017 and 1Q18 reports have been filed.

You had conveyed OMHE business plan in Feb 2017. Since then OMHE acquired new business, inducted scientists, established advanced Biotech R&D lab, conducting research to develop cannabinoid-based drug therapies. Latest update was provided on 11/14/2017: cannabinoid-based pain treatment medicine is ready to be marketed; talks are underway with large European companies. Target markets include North America, Europe, Australia and Asia.

I am satisfied with OMHE's progress!!